EU Council Takes Only Small Steps Towards Consensus On HTA Regulations
EU member state have several concerns about the European Commission’s plans for improving cooperation on health technology assessments, making it difficult for the Council of the EU to reach a common position on the proposals.
You may also be interested in...
The European Medicines Agency has identified key areas where stakeholders want to see it deliver a real change over the next five years.
Pharmaceutical companies should be obliged to carry out comparative trials, according to analysis from Germany’s Institute For Quality and Efficiency in Healthcare, IQWiG.
Legislation that would introduce EU-wide joint clinical assessments has moved a step forward after the European Parliament adopted its version of the proposals.